Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients

Cell Mol Immunol. 2020 Oct;17(10):1095-1097. doi: 10.1038/s41423-020-00523-5. Epub 2020 Sep 7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / chemistry*
  • Antibodies, Neutralizing / genetics
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / chemistry*
  • Antibodies, Viral / genetics
  • Antibodies, Viral / immunology
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / virology
  • Betacoronavirus / genetics
  • Betacoronavirus / immunology*
  • Betacoronavirus / pathogenicity
  • Binding Sites
  • COVID-19
  • Convalescence
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / virology
  • Epitope Mapping
  • Epitopes / chemistry*
  • Epitopes / genetics
  • Epitopes / immunology
  • Gene Expression
  • Host-Pathogen Interactions / genetics
  • Host-Pathogen Interactions / immunology
  • Humans
  • Immune Sera / chemistry
  • Immunoconjugates / chemistry
  • Immunoconjugates / genetics
  • Immunoconjugates / immunology
  • Models, Molecular
  • Neutralization Tests
  • Pandemics
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / virology
  • Protein Array Analysis
  • Protein Binding
  • Protein Conformation, alpha-Helical
  • Protein Conformation, beta-Strand
  • Protein Interaction Domains and Motifs
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / chemistry*
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Epitopes
  • Immune Sera
  • Immunoconjugates
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2